Combined intermittent and sustained hypoxia is a novel and deleterious cardio-metabolic phenotype-V45I6 Combined intermittent and sustained hypoxia is a novel and deleterious cardio-metabolic phenotype-V45I6 Download Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy-V45I6 Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al-V45I6
